Methodological standardization for a multi-institutional in vivo trial of localized 31P MR spectroscopy in human cancer research. In vitro and normal volunteer studies

NMR in Biomedicine

Volumn 17, Issue 6, 2004, Pages 382-391

  Arias Mendoza, F ^a,l   Zakian, K ^b   Schwartz, A ^c   Howe, F A ^d   Koutcher, J A ^b   Leach, M O ^c   Griffiths, J R ^d   Heerschap, A ^e   Glickson, J D ^f   Nelson, S J ^g   Evelhoch, J L ^h   Charles, H C ⁱ   Brown, T R ^a   Murphy Boesch, Joseph ^j   Stoyanova, Radka ^j   Kappler, Francis ^j   Negendank, William G ^j   Ballon, Douglas ^b   Payne, Geoffrey ^k  

^a Fox Chase Center   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j FOX CHASE CANCER CENTER   (United States)

^k S Ronen at The Royal Marsden Hosp   (United Kingdom)

^l Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

more..

Author keywords

Human cancer research; Localized 31P MR spectroscopy; Methodological standardization; Multi institutional trial; Non invasive; Quality control

Indexed keywords

HEALTH CARE; IRRADIATION; MAGNETIC RESONANCE SPECTROSCOPY; MUSCLE; QUALITY CONTROL; TUMORS;

HUMAN CANCER; RADIOFREQUENCY PROBE; VARIANCE COEFFICIENTS;

ONCOLOGY;

CREATINE PHOSPHATE; NUCLEOTIDE; PHOSPHATE; PHOSPHORUS 31; PROTON;

ARTICLE; CANCER RESEARCH; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSTANTS AND COEFFICIENTS; ERROR; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; MUSCLE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON RADIATION; QUALITY CONTROL; RADIOFREQUENCY; SCINTILLATION PROBE; SIGNAL NOISE RATIO; STANDARDIZATION; VARIANCE; VOLUNTEER;

ETHANOLAMINES; HUMANS; INTERNATIONALITY; MAGNETIC RESONANCE SPECTROSCOPY; MULTICENTER STUDIES; MUSCLE, SKELETAL; NEOPLASMS; PHOSPHORUS ISOTOPES; PHOSPHORYLCHOLINE; QUALITY ASSURANCE, HEALTH CARE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RESEARCH; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 5044237124     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.915     Document Type: Article

References (15)

1. 31P-NMR studies of a human tumour in situ. Lancet 1983; 1(8339): 1435-1436.
2. Li CW, Kuesel AC, Padavic-Shaller KA, Murphy-Boesch J, Eisenberg BL, Schmidt RG, von Roemeling RW, Patchefsky AS, Brown TR, Negendank WG. Metabolic characterization of human soft tissue sarcomas in vivo and in vitro using proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 1996; 56(13): 2964-2972.
3. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992; 5(5): 303-324.
4. Negendank WG, Padavic-Shaller KA, Li CW, Murphy-Boesch J, Stoyanova R, Krigel RL, Schilder RJ, Smith MR, Brown TR. Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 1995; 55(15): 3286-3294.
5. Furman E, Margalit R, Bendel P, Horowitz A, Degani H. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun. 1991; 3(9): 287-297.
6. 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J. Cell Physiol. 1994; 158(1): 180-186.
7. 31P magnetic resonance spectroscopy. Cancer Res. 1986; 46(8): 4087-4090.
8. Arias-Mendoza F, Smith MR, Brown TR. Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Acad. Radiol. 2004; 11(4): 368-376.
9. 1 inhomogeneity. Magn. Reson. Med. 1998; 39(3): 429-438.
10. FDA. Guidance for the Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices. Center for Devices and Radiological Health: Rockville, MD, 1998.
11. IEC-60601-2-33. Medical Electrical Equipment, Part 2: Particular Requirements for the Safety of Magnetic Resonance Equipment for Medical Diagnosis. International Electrochemical Commission: Geneva, 1995.
12. Schwarz AJ, Rijpkema M, Collins DJ, Payne GS, Prock T, Woodward AC, Heerschap A, Leach MO. SAR and tissue heating with a clinical (31)P MRS protocol using surface coils, adiabatic pulses, and proton-decoupling. Magn. Reson. Med. 2000; 44(5): 692-700.
13. 1 relaxation times of phosphorylated metabolites in human calf muscle at 1.5 Tesla. Magn. Reson. Med. 1995; 33(3): 417-421.
14. Moyher SE, Vigneron DB, Nelson SJ. Surface coil MR imaging of the human brain with an analytic reception profile correction. J. Magn. Reson. Imag. 1995; 5(2): 139-144.
15. 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed. 1993; 6(3): 173-180.